US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,834.82

+26.851.49%

Number of Gainers:8

Number of Losers:11

Number of Flat:- -

PE:- -

High:1,846.22

Open:1,807.96

Low:1,807.96

Close:1,807.97

Volume:94.07M

Turnover:7.41B

Market Cap:1.49T

Float Cap:1.46T

Loading ...

Gilead Sciences Announces Dividend of R$ 0.2394442440 Per Unit for Brgildbdr 000

Moderna Stock Gets Sell Call As Oncology Hopes Face Valuation Test

Simply Wall St.

Vir Biotechnology Appoints Aziz Sawaf as Chief Financial Officer

THOMSON REUTERS

Coty Names Kara Langan General Manager, U.S. Consumer Beauty Division

Pfizer says Phase 2 study of tilrekimig met primary endpoint

Pfizer Says Tilrekimig Hits Phase 2 Atopic Dermatitis Endpoint with 62.5% EASI-75 at Week 16

Pfizer - no Serious Adverse Events Related to Tilrekimig in Phase 2 Study

THOMSON REUTERS

Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study

THOMSON REUTERS

Pfizer - Tilrekimig Well-Tolerated with Teae Rates Comparable to Placebo

THOMSON REUTERS

Pfizer - 62.5% of Patients on Tilrekimig 450 Mg Q2w Achieve Easi-75 vs 19.9% Placebo

THOMSON REUTERS

Pfizer - Phase 2 Study Meets Primary Endpoint with Significant Easi-75 Improvement at Week 16

THOMSON REUTERS

Alpha Pro Tech Director Donna Millar Disposes of 15,000 Common Shares Worth $75,600

Agilent Technologies Inc. Stock Underperforms Wednesday When Compared to Competitors

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors

Moderna Inc. Stock Sheds 5.4%, Underperforms Peers

BioNTech CEO Uğur Şahin Disposes of $6.48 Million in Common Shares

Citi Downgrades Moderna Stock, Warning $80 Billion Valuation Asks Too Much of Cancer Pipeline

Corvus announces initiation of Phase 1b clinical trial of soquelitinib

Corvus Starts Phase 1b Trial of Soquelitinib in Hidradenitis Suppurativa Patients

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BK4568/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1834.8213,"timestamp":1791403199999,"preClose":1807.9673,"halted":0,"volume":94070954,"delay":0,"changeRate":0.014853,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":26.854004,"latestTime":"10-07 16:00:00 EDT","open":1807.9589,"high":1846.2249,"low":1807.9589,"amount":7413625263.41385,"amplitude":0.021165,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791446400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.738387,"peRate":45.966788,"turnoverRate":0.00678,"increases":8,"decrements":11,"flats":0,"marketCap":1491961574063,"floatMarketCap":1456681952673},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1846.2249,"amplitude":0.021165,"preClose":1807.9673,"low":1807.9589,"pbRate":"4.738387","latestPrice":1834.8213,"volume":94070954,"delay":0,"open":1807.9589,"prevYearClose":1637.1339,"prevWeekClose":1811.1105,"prevMonthClose":1862.664,"prevQuarterClose":1862.664,"fiveDayClose":1862.664,"twentyDayClose":1835.2891,"sixtyDayClose":1685.2764,"secType":"PLATE","market":"US","turnoverRate":0.00678,"peRate":45.966788,"marketCap":1491961574063,"floatMarketCap":1456681952673,"timestamp":1791403199999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":8,"down":11,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672500697","title":"Gilead Sciences Announces Dividend of R$ 0.2394442440 Per Unit for Brgildbdr 000","url":"https://stock-news.laohu8.com/highlight/detail?id=2672500697","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672500697?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:56","pubTimestamp":1790863001,"startTime":"0","endTime":"0","summary":"Gilead Sciences announces dividend of R$ 0.2394442440 per unit for BRGILDBDR 000Gilead declared a 3Q 2026 dividend of R$ 0.2394 per unit for ISIN BRGILDBDR000.Shares trade ex-rights from Sept. 11, 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL7w2sZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","BIB","IE00B3T34201.USD","LU0889565916.HKD","LU1066053197.SGD","LU1934455863.HKD","BMED","LU1023059063.AUD","BK4139","LU0122379950.USD","LU0823416689.USD","LU0965508806.USD","MEDI","LU0859254822.USD","LU0965509010.AUD","IE00B7SZLL34.SGD","LU1037948541.HKD","SG9999015978.USD","IE00B19Z3B42.SGD","LU1430594728.SGD","IE00BZ1G4Q59.USD","IE0002270589.USD","TMED","LU1061106388.HKD","BK4568","LU0058720904.USD","LU1057294990.SGD","LU1571399168.USD","BK4550","GILD","LU1778281490.HKD","BK4588","LU1066051498.USD","LU0861579265.USD","LU1934455277.USD","LU0320765992.SGD","SG9999015945.SGD","IE00B19Z3581.USD","LU2089984988.USD","BBH","LU2357627491.SGD","LU0114720955.EUR","IBBQ","LU1037948897.HKD","LU0965509283.SGD","LU0109394709.USD","IBB","BK4585","TBXU","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672763612","title":"Moderna Stock Gets Sell Call As Oncology Hopes Face Valuation Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2672763612","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672763612?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:15","pubTimestamp":1790860524,"startTime":"0","endTime":"0","summary":"Moderna appointed former executive Juan Andres as Chief Operating Officer in early October 2026, a new role focused on scaling manufacturing and execution as the oncology pipeline, including intismeran autogene, moves toward potential commercialization.\nThe return of Andres, who previously led the rapid build-out of Moderna's COVID-19 vaccine production network, highlights management's emphasis on operational discipline at a time when some analysts question how much oncology success is...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/128680956-card/1789197794273","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/128680956-card/1789197794273"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrna/moderna/news/moderna-stock-gets-sell-call-as-oncology-hopes-face-valuatio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrna/moderna/news/moderna-stock-gets-sell-call-as-oncology-hopes-face-valuatio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4551","BK4532","BK4568","BK4585","MRNX","MRNY","IDNA","GNOM","BK4548","WDNA","BK4534","LGHT","BK4533","BK4139","BK4588","MRNA","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672675248","title":"Vir Biotechnology Appoints Aziz Sawaf as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2672675248","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672675248?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:30","pubTimestamp":1790857802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA4LKBSP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VIR","BK4535","BK4585","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751318","title":"Coty Names Kara Langan General Manager, U.S. Consumer Beauty Division","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751318","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751318?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:05","pubTimestamp":1790852708,"startTime":"0","endTime":"0","summary":"Coty names Kara Langan general manager, U.S. consumer beauty divisionCoty named Kara Langan general manager, Consumer Beauty U.S., effective Oct. 13, based in New York.Langan previously served as Ever","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL3YH6rJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","IE00B19Z3B42.SGD","BK4533","FHLC","LU1228905540.USD","LU0345770308.USD","LU1221951046.USD","LU1551013425.SGD","FTXH","XLV","IE00BN8TJ469.HKD","IE00B3PB1722.GBP","TRUH","LU2505996681.GBP","RSPS","JNJ","BK4585","LU1066053197.SGD","BK4581","LU2750360641.GBP","LU0912757837.SGD","LU1074936037.SGD","BK4532","PJP","IHE","JDOC","LU1061106388.HKD","GDOC","LU1778281490.HKD","MEDX","LU2750360997.AUD","LU1196500208.SGD","IE00B2B36J28.USD","COTY","LU1506573853.SGD","RXL","SGXZ57979304.SGD","SG9999001176.SGD","LU0128525929.USD","IXJ","LU0545562505.USD","KVUE","IYH","VHT","LU0943347566.SGD","LU0345769128.USD","BK4588","BK4568","IE00BLSP4452.SGD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672756456","title":"Pfizer says Phase 2 study of tilrekimig met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2672756456","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672756456?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:10","pubTimestamp":1790849423,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) presented detailed results from an ongoing Phase 2 study investigating tilrekimig in adults with moderate-to-severe atopic dermatitis....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pfizer-says-phase-2-study-of-tilrekimig-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pfizer-says-phase-2-study-of-tilrekimig-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1066053197.SGD","BK4007","IE00BBT3K403.USD","PFE","LU0225771236.USD","IE00BLSP4239.USD","BK4581","LU0306807586.USD","LU0321505439.SGD","LU0321505868.SGD","BK4592","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4585","BK4599","LU1894683348.USD","SG9999002232.USD","BK4568","LU0225284248.USD","LU0868494617.USD","LU1023059063.AUD","LU0122379950.USD","SG9999001176.USD","OZEM","LU1894683264.USD","SG9999011175.SGD","IE000M9KFDE8.USD","BK4550","LU0170899867.USD","LU1883839398.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","LU0234572021.USD","LU0289739699.SGD","IE00B3T34201.USD","LU2596442595.SGD","LU1057294990.SGD","LU0306806265.USD","SG9999002224.SGD","LU0985481810.HKD","LU1066051498.USD","BK4534","IE00BLSP4452.SGD","SG9999003800.SGD","IE0002270589.USD","LU0058720904.USD","BK4533","LU0456855351.SGD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672375367","title":"Pfizer Says Tilrekimig Hits Phase 2 Atopic Dermatitis Endpoint with 62.5% EASI-75 at Week 16","url":"https://stock-news.laohu8.com/highlight/detail?id=2672375367","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672375367?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:31","pubTimestamp":1790836262,"startTime":"0","endTime":"0","summary":"Pfizer says tilrekimig hits Phase 2 atopic dermatitis endpoint with 62.5% EASI-75 at week 16Pfizer presented Phase 2 results for tilrekimig in moderate-to-severe atopic dermatitis at the EADV congress","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL9zmvR2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","LU0225284248.USD","LU2596442595.SGD","SG9999001176.USD","LU0225771236.USD","SG9999002224.SGD","BK4592","LU0122379950.USD","SG9999013999.USD","IE00B19Z3581.USD","SG9999011175.SGD","BK4534","LU0306807586.USD","BK4588","LU1894683348.USD","LU0058720904.USD","LU0289739699.SGD","LU1023059063.AUD","LU1894683264.USD","SG9999002232.USD","LU1066053197.SGD","IE0002270589.USD","LU1057294990.SGD","BK4550","BK4581","LU0321505868.SGD","BK4585","LU0985481810.HKD","LU1883839398.USD","LU0456855351.SGD","IE00BBT3K403.USD","LU0170899867.USD","LU0321505439.SGD","BK4533","BK4599","IE00B3T34201.USD","LU0234572021.USD","PFE","BK4568","LU0306806265.USD","SG9999001176.SGD","LU1066051498.USD","OZEM","IE00BLSP4239.USD","IE000M9KFDE8.USD","LU0868494617.USD","BK4007","SG9999003800.SGD","IE00BLSP4452.SGD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672573738","title":"Pfizer - no Serious Adverse Events Related to Tilrekimig in Phase 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672573738","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672573738?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","SG9999002224.SGD","IE00B19Z3B42.SGD","LU0306806265.USD","LU1883839398.USD","LU0122379950.USD","IE00B19Z3581.USD","IE00BLSP4239.USD","SG9999003800.SGD","LU1894683348.USD","LU0170899867.USD","BK4588","IE000M9KFDE8.USD","IE00BLSP4452.SGD","IE0002270589.USD","LU1894683264.USD","BK4585","SG9999001176.SGD","LU0058720904.USD","LU0306807586.USD","LU0985481810.HKD","SGXZ57979304.SGD","LU0321505439.SGD","BK4581","BK4599","LU0456855351.SGD","LU0225771236.USD","LU0321505868.SGD","IE00B3T34201.USD","LU0868494617.USD","SG9999011175.SGD","LU2596442595.SGD","BK4007","BK4592","LU1023059063.AUD","IE00BBT3K403.USD","LU0234572021.USD","BK4550","LU0289739699.SGD","SG9999002232.USD","LU1066053197.SGD","LU1057294990.SGD","SG9999001176.USD","SG9999013999.USD","BK4533","BK4568","OZEM","LU1066051498.USD","LU0225284248.USD","PFE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672382737","title":"Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672382737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672382737?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0225284248.USD","LU1894683264.USD","LU0225771236.USD","SG9999001176.USD","IE000M9KFDE8.USD","OZEM","LU1066053197.SGD","PFE","IE00BBT3K403.USD","LU0170899867.USD","IE00B19Z3581.USD","LU0456855351.SGD","LU0985481810.HKD","LU1057294990.SGD","LU0868494617.USD","LU2596442595.SGD","BK4581","SGXZ57979304.SGD","BK4007","BK4585","SG9999013999.USD","BK4534","BK4568","IE00B3T34201.USD","BK4599","LU1066051498.USD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4533","LU1894683348.USD","LU1023059063.AUD","LU0058720904.USD","LU0122379950.USD","LU0321505439.SGD","LU0321505868.SGD","SG9999001176.SGD","BK4592","IE00BLSP4239.USD","LU1883839398.USD","SG9999002224.SGD","LU0306806265.USD","BK4588","SG9999003800.SGD","LU0289739699.SGD","BK4550","LU0234572021.USD","IE00BLSP4452.SGD","LU0306807586.USD","SG9999011175.SGD","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672338737","title":"Pfizer - Tilrekimig Well-Tolerated with Teae Rates Comparable to Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2672338737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672338737?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0321505439.SGD","BK4581","BK4568","LU0456855351.SGD","LU0985481810.HKD","LU0225771236.USD","OZEM","LU1066051498.USD","PFE","SG9999011175.SGD","SG9999001176.SGD","LU1894683348.USD","SG9999002232.USD","IE00BLSP4452.SGD","IE00B19Z3581.USD","LU0306807586.USD","BK4585","BK4588","LU0225284248.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999003800.SGD","IE00BLSP4239.USD","BK4533","LU0170899867.USD","LU0289739699.SGD","SG9999001176.USD","SG9999002224.SGD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU2596442595.SGD","BK4534","IE0002270589.USD","BK4007","IE000M9KFDE8.USD","BK4599","LU1066053197.SGD","SGXZ57979304.SGD","LU0058720904.USD","LU1894683264.USD","BK4550","LU0234572021.USD","LU0122379950.USD","LU0306806265.USD","LU1883839398.USD","IE00BBT3K403.USD","IE00B3T34201.USD","LU0868494617.USD","SG9999013999.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672334737","title":"Pfizer - 62.5% of Patients on Tilrekimig 450 Mg Q2w Achieve Easi-75 vs 19.9% Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2672334737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672334737?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0321505439.SGD","BK4581","BK4568","LU0456855351.SGD","LU0985481810.HKD","LU0225771236.USD","OZEM","LU1066051498.USD","PFE","SG9999011175.SGD","SG9999001176.SGD","LU1894683348.USD","SG9999002232.USD","IE00BLSP4452.SGD","IE00B19Z3581.USD","LU0306807586.USD","BK4585","BK4588","LU0225284248.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999003800.SGD","IE00BLSP4239.USD","BK4533","LU0170899867.USD","LU0289739699.SGD","SG9999001176.USD","SG9999002224.SGD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU2596442595.SGD","BK4534","IE0002270589.USD","BK4007","IE000M9KFDE8.USD","BK4599","LU1066053197.SGD","SGXZ57979304.SGD","LU0058720904.USD","LU1894683264.USD","BK4550","LU0234572021.USD","LU0122379950.USD","LU0306806265.USD","LU1883839398.USD","IE00BBT3K403.USD","IE00B3T34201.USD","LU0868494617.USD","SG9999013999.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672273733","title":"Pfizer - Phase 2 Study Meets Primary Endpoint with Significant Easi-75 Improvement at Week 16","url":"https://stock-news.laohu8.com/highlight/detail?id=2672273733","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672273733?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001176.USD","BK4599","IE00B3T34201.USD","LU0170899867.USD","BK4534","SG9999011175.SGD","LU0289739699.SGD","SG9999002224.SGD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","BK4568","LU0122379950.USD","LU2596442595.SGD","BK4592","IE00BBT3K403.USD","LU0868494617.USD","LU1894683348.USD","OZEM","SG9999002232.USD","BK4550","SG9999003800.SGD","BK4581","LU0225771236.USD","LU0985481810.HKD","LU0234572021.USD","LU1894683264.USD","PFE","BK4533","SG9999001176.SGD","LU1883839398.USD","BK4585","SGXZ57979304.SGD","BK4007","LU0306806265.USD","LU1066053197.SGD","IE0002270589.USD","IE00B19Z3581.USD","LU0321505868.SGD","BK4588","LU0321505439.SGD","LU0058720904.USD","IE00BLSP4239.USD","LU0456855351.SGD","LU1066051498.USD","SG9999013999.USD","LU0306807586.USD","LU1023059063.AUD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU0225284248.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672787788","title":"Alpha Pro Tech Director Donna Millar Disposes of 15,000 Common Shares Worth $75,600","url":"https://stock-news.laohu8.com/highlight/detail?id=2672787788","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672787788?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:15","pubTimestamp":1790802937,"startTime":"0","endTime":"0","summary":"Alpha Pro Tech director Donna Millar disposes of 15,000 common shares worth $75,600Alpha Pro Tech director Donna Millar reported net sales of 15,000 common shares on Sept. 28, 2026 at USD 5.04.Holding","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDLbKBrMv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alpha Pro Tech Director Donna Millar Disposes of 15,000 Common Shares Worth $75,600","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APT","BK4568","BK4086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672787680","title":"Agilent Technologies Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672787680","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672787680?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:51","pubTimestamp":1790801460,"startTime":"0","endTime":"0","summary":"DJ Agilent Technologies Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Agilent Technologies Inc.  slipped 1.55% to $172.31 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,651.54 and Dow Jones Industrial Average  falling 0.86% to 50,906.05.This was the stock's second consecutive day of losses.Agilent Technologies Inc. closed 2.68% short of its 52-week high of $177.05, which the company achieved on September 29th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Thermo Fisher Scientific Inc.  fell 0.67% to $675.05, Danaher Corp.  fell 1.84% to $221.55, and Abbott Laboratories  fell 2.10% to $98.83.Trading volume  eclipsed its 50-day average volume of 2.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["A","IE00BQXX3D17.EUR","LU1721428933.USD","ABT","GNMX","LU2023250504.SGD","LU1721429741.USD","BK4592","LU2125909916.SGD","HRTS","IE00B19Z8W00.USD","LU2063271972.USD","FMED","LU0312595415.SGD","LU2764263203.CNY","LU1720051017.SGD","LU0820561818.USD","LU0347712357.USD","LU2125909759.SGD","IE00BZ1G4Q59.USD","LU0266013472.USD","LU1165135440.EUR","IE00BJJMRZ35.SGD","LU1551013342.USD","LU1803068623.USD","LU2764262908.HKD","DHR","BK4585","LU1804176565.USD","BK4534","LU1923622291.USD","LU1057294990.SGD","LU1989771016.USD","LU0058720904.USD","LU0345770308.USD","TMO","LU1983299246.USD","LU0048573561.USD","LU1721429402.USD","LU1854104046.USD","PJP","IE00B4R5TH58.HKD","TMED","IE00BQXX3F31.USD","LU0957791311.USD","LU0061474960.USD","BK4568","LU0708994859.HKD","IHI","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782095","title":"Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782095","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782095?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:36","pubTimestamp":1790800560,"startTime":"0","endTime":"0","summary":"DJ Abbott Laboratories Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Abbott Laboratories  slid 2.10% to $98.83 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,651.54 and Dow Jones Industrial Average  falling 0.86% to 50,906.05.This was the stock's third consecutive day of losses.Abbott Laboratories closed 27.04% short of its 52-week high of $135.45, which the company reached on October 1st.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 1.06% to $264.74, Pfizer Inc.  fell 0.70% to $28.52, and Merck & Co. Inc.  fell 2.66% to $145.31.Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","LU0912757837.SGD","LU2324357040.USD","IYH","LU0477156953.USD","LU2430703095.HKD","SG9999003800.SGD","GDOC","LU1674673428.USD","LU0942090050.USD","LU0545039389.USD","LU1585245621.USD","LU0545562505.USD","LU2125154778.USD","LU1228905037.USD","IE000SO60NU8.SGD","LU0225771236.USD","PFE","LU1023059063.AUD","LU0661504455.SGD","LU2505996509.AUD","LU0868494708.USD","LU0210528500.USD","LU0648001328.SGD","LU1941712264.USD","LU0225284248.USD","LU0820561818.USD","JNJ","IE000M9KFDE8.USD","LU2129689605.HKD","LU1989772840.SGD","LU1934455277.USD","BK4559","LU2089984988.USD","RXL","LU1989772923.USD","LU0070302665.USD","LU2211815571.USD","HRTS","LU1883839398.USD","LU0964807845.USD","LU1506573853.SGD","LU0965509101.SGD","LU0345769631.USD","LU2756315318.SGD","IE00B7SZLL34.SGD","LU1057294990.SGD","BMED","LU1934455863.HKD","LU0787776722.HKD","LU1061106388.HKD","LU1914381329.SGD","LU0321505868.SGD","BK4533","IE0009355771.USD","TMED","LU2456880835.USD","LU2129689514.USD","XLV","IE00BFXG1179.USD","LU0053666078.USD","LU2491049909.HKD","LU0689626769.HKD","IE00B1BXHZ80.USD","LU1674673691.USD","IE00BDGV0183.EUR","LU1003077747.HKD","LU0289961442.SGD","LU1043141123.HKD","LU0689472784.USD","LU0211331839.USD","IE0000B7K699.USD","IE00BJT1NW94.SGD","BK4566","IE00B19Z3B42.SGD","LU2468319806.SGD","SG9999001176.USD","LU0511384066.AUD","LU1670627923.USD","BK4550","LU2471134879.HKD","LU0234570918.USD","LU2237957811.SGD","IE00BLSP4239.USD","LU0234572021.USD","SGXZ57979304.SGD","LU0466842654.USD","IE00BBT3K403.USD","LU2112291526.USD","LU2125909593.SGD","LU2433249047.HKD","LU0098860793.USD","PPH","SG9999002232.USD","SGXZ80539844.SGD","IE0002270589.USD","LU1121112475.USD","LU1244550494.USD","LU2403377893.USD","FTXH","LU1032955483.USD","LU2596442595.SGD","LU0072461881.USD","IE00BKVL7J92.USD","LU2347655156.SGD","LU0472753341.HKD","BK4532","LU0426412945.USD","LU0114720955.EUR","LU1074936037.SGD","LU0868494617.USD","LU2357627491.SGD","LU0320765646.SGD","FHLC","BK4599","IE00BVYPNW00.USD","LU0985320562.USD","LU0057025933.USD","LU0965508806.USD","LU1989771016.USD","LU0210536198.USD","LU1778281490.HKD","LU2750360997.AUD","LU2023250504.SGD","LU1496350502.SGD","LU1043141396.HKD","BK4592","BK4504","BK4082","LU0306807586.USD","LU2236285917.USD","LU2471134952.CNY","MEDX","LU0345770993.USD","LU1093756325.SGD","LU1989763690.USD","LU1066051811.HKD","LU2361044949.HKD","LU1551013425.SGD","LU0289739343.SGD","LU2430703178.SGD","LU1983299246.USD","LU1069347547.HKD","LU2896262040.SGD","LU2592432038.USD","LU2487616109.SGD","LU1093756168.USD","SG9999014559.SGD","LU0238689110.USD","LU0208291251.USD","SG9999014575.USD","LU1221951046.USD","LU0006306889.USD","LU0861579265.USD","LU0949170772.SGD","SG9999001176.SGD","LU0683600562.USD","LU1732800096.USD","LU2461242641.AUD","LU0070217475.USD","SG9999014567.USD","LU0289739699.SGD","LU1691799644.USD","IE00B3T34201.USD","LU0058720904.USD","ABT","IE0034235303.USD","LU2023250843.SGD","LU1721429402.USD","LU1974910355.USD","LU1037948541.HKD","LU2361044865.SGD","IE000F7OJYX1.SGD","IXJ","LU2237957902.USD","LU0640476718.USD","LU1670628061.USD","IE00BVYPNV92.GBP","LU0553294199.USD","LU1162221912.USD","LU1917777945.USD","LU2125909247.SGD","LU2430703251.USD","LU1201861249.SGD","LU0306806265.USD","LU0265550946.USD","BK4581","IE00BN8TJ469.HKD","LU0170899867.USD","LU0320765489.SGD","LU0321505439.SGD","IE0002141913.USD","LU0792757196.USD","IE000MB6IJN5.SGD","LU0859254822.USD","SG9999001440.SGD","IE00B4R5TH58.HKD","LU1894683348.USD","LU0265550359.USD","LU2361045086.USD","LU0980610538.SGD","LU2471134796.USD","LU1066051225.USD","BK4568","LU0130102774.USD","LU0432979614.USD","LU0994945656.USD","BK4516","SG9999013999.USD","LU0456855351.SGD","LU0889566641.SGD","LU1699723380.USD","LU2125154935.USD","LU2023250330.USD","BK4588","IE00B19Z3581.USD","IHI","TRUH","LU1718418525.SGD","LU0069063385.USD","LU1989763427.SGD","IE00BGHQF631.EUR","IE00BZ1G4Q59.USD","LU1221951129.SGD","LU0130517989.USD","LU1941712348.USD","LU2417539215.USD","LU1037948897.HKD","LU1721429741.USD","IE00BFTCPJ56.SGD","LU2213496289.HKD","LU1066053197.SGD","LU0738911758.USD","LU1116320901.HKD","IE000BZT7R73.USD","LU0124676726.USD","IE0001KFT4U8.USD","PJP","LU0106261372.USD","LU0345769128.USD","SGXZ41872573.SGD","LU1228905540.USD","SG9999014542.SGD","LU0985481810.HKD","LU1116320737.USD","SG9999015341.SGD","LU1629891620.HKD","SG9999002224.SGD","LU0122379950.USD","PAWZ","LU2756315664.SGD","SG9999015358.SGD","LU1280957306.USD","VHT","IE00BSNM7G36.USD","LU1929549753.HKD","LU2505996681.GBP","BK4585","LU1267930813.SGD","LU1934455194.USD","LU1732799900.SGD","LU2491050154.USD","LU1430594728.SGD","BK4007","LU0203347892.USD","BK4534","LU2133065610.SGD","LU1551013342.USD","LU1035773651.USD","LU2750360641.GBP","LU0795875169.SGD","LU2491050071.SGD","LU0965509010.AUD","LU2360032135.SGD","LU0795875086.SGD","LU1059921491.USD","LU2602419157.SGD","LU1032466523.USD","LU0820561909.HKD","LU0882574055.USD","IE00BLSP4452.SGD","MRK","LU2129689431.USD","IE000WAW04H5.SGD","LU0943347566.SGD","IE00B42XCP33.USD","IHE","IE00B3PB1722.GBP","SG9999011175.SGD","LU2106854487.HKD","SGXZ23171101.USD","OZEM","LU0266013472.USD","LU0820562030.AUD","LU1196500208.SGD","LU0345770308.USD","JDOC","LU1935042991.SGD","IE00B2B36J28.USD","LU1923622614.USD","LU0426417589.USD","LU0965509283.SGD","LU0823416689.USD","LU2471134523.USD","SG9999004303.SGD","LU1894683264.USD","LU1291159041.SGD","LU1571399168.USD","LU1066051498.USD","LU1244550221.USD","LU0162691827.USD","LU1261432733.SGD","LU1244550577.SGD","IE00BJJMRZ35.SGD","LU1145028129.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672774782","title":"Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672774782","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672774782?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:35","pubTimestamp":1790800500,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 1.47% to $149.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,651.54 and Dow Jones Industrial Average  falling 0.86% to 50,906.05.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 5.24% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 1.06% to $264.74, Pfizer Inc.  fell 0.70% to $28.52, and Abbott Laboratories  fell 2.10% to $98.83.Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU0882574055.USD","BK4568","IE00B19Z3581.USD","BK4585","LU1037948897.HKD","LU1839511570.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU2357627491.SGD","LU1023059063.AUD","BK4583","LU1674673691.USD","LU0122379950.USD","TBXU","GILD","LU0965509101.SGD","LU1934455863.HKD","BK4588","IE0002270589.USD","SG9999015986.USD","LU0965508806.USD","IBB","SG9999015952.SGD","BK4532","LU2468319806.SGD","LU0114720955.EUR","LU1934455194.USD","SG9999015945.SGD","LU1061106388.HKD","LU2089984988.USD","LU1066053197.SGD","LU0823416689.USD","LU1934455277.USD","IE00B7SZLL34.SGD","LU0965509010.AUD","LU1066051498.USD","BK4578","BBH","LU2112291526.USD","LU1057294990.SGD","BK4550","BMED","LU2087621335.USD","LU2324357040.USD","SG9999015978.USD","LU0889565916.HKD","LU0289739699.SGD","LU1430594728.SGD","LU0234570918.USD","LU0861579265.USD","IE00B19Z3B42.SGD","LU0109394709.USD","IE00BSNM7G36.USD","LU1585245621.USD","LU0320765992.SGD","LU1571399168.USD","BK4566","MEDI","TMED","BK4139","LU0058720904.USD","LU0859254822.USD","IBBQ","LU1778281490.HKD","LU0965509283.SGD","BIB","LU1037948541.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672278203","title":"Moderna Inc. Stock Sheds 5.4%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2672278203","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672278203?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:33","pubTimestamp":1790800380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slipped 5.4% to $192.57 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,861.06 and the Dow Jones Industrial Average falling 0.9% to 50,906.05.Moderna Inc. closed 7.8% short of its 52-week high of $208.90, which the company reached on September 29th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $264.74, Pfizer Inc. fell 0.7% to $28.52, and Gilead Sciences Inc. fell 1.47% to $149.05.Trading volume totaled 20.1 million, compared to the 50-day average of 19.4 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","BK4568","BK4585","LU1037948897.HKD","IE00BZ1G4Q59.USD","MRNX","LU2357627491.SGD","BK4534","LU1023059063.AUD","BK4583","LU1674673691.USD","TBXU","GILD","LU1934455863.HKD","GNOM","IE0002270589.USD","SG9999015986.USD","IBB","SG9999015952.SGD","BK4532","MRNY","LGHT","LU1934455194.USD","SG9999015945.SGD","LU2089984988.USD","LU1066053197.SGD","WDNA","LU1934455277.USD","LU1066051498.USD","MRNA","BBH","LU1057294990.SGD","BK4550","BMED","LU2087621335.USD","LU0289739699.SGD","LU1430594728.SGD","BK4533","IE00B19Z3B42.SGD","LU0109394709.USD","IE00BSNM7G36.USD","LU0320765992.SGD","BK4566","MEDI","TMED","BK4139","LU0058720904.USD","IBBQ","BIB","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782472","title":"BioNTech CEO Uğur Şahin Disposes of $6.48 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782472","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782472?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:30","pubTimestamp":1790800256,"startTime":"0","endTime":"0","summary":"BioNTech CEO Uur ahin disposes of $6.48 million in common sharesBioNTech CEO Ugur Sahin sold 66,000 ordinary shares on Sept. 29-30, 2026.Sales priced at USD 98.2591 and USD 98.1203 per share.Direct ho","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL955BQp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioNTech CEO Uğur Şahin Disposes of $6.48 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4548","BK4535","BK4588","BK4568","BNTX","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782968","title":"Citi Downgrades Moderna Stock, Warning $80 Billion Valuation Asks Too Much of Cancer Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782968","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782968?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:15","pubTimestamp":1790799300,"startTime":"0","endTime":"0","summary":"Moderna's eye-watering rally has officially outpaced its fundamentals, according to one analyst, prompting a downgrade at a major Wall Street firm.Citi's Geoff Meacham cut his rating on Moderna shares","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4533","WDNA","BK4532","MRNX","BK4548","GNOM","MRNA","BK4139","BK4585","IDNA","BK4534","LGHT","BK4588","MRNY","BK4501","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782978","title":"Corvus announces initiation of Phase 1b clinical trial of soquelitinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782978","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782978?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:10","pubTimestamp":1790799031,"startTime":"0","endTime":"0","summary":"Corvus Pharmaceuticals (CRVS) announced that enrollment has begun in its Phase 1b clinical trial of soquelitinib for the treatment of patients with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/corvus-announces-initiation-of-phase-1b-clinical-trial-of-soquelitinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/corvus-announces-initiation-of-phase-1b-clinical-trial-of-soquelitinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4139","MEDX","CRVS","NVIB","GDOC","HYLG","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782367","title":"Corvus Starts Phase 1b Trial of Soquelitinib in Hidradenitis Suppurativa Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782367","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782367?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:06","pubTimestamp":1790798806,"startTime":"0","endTime":"0","summary":"Corvus starts Phase 1b trial of soquelitinib in hidradenitis suppurativa patientsCorvus Pharmaceuticals began enrolling a Phase 1b trial of soquelitinib in hidradenitis suppurativa, expanding developm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL1DBD0N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4568","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","SG9999014013.SGD","LU2095319765.USD","SG9999014021.USD","BK4585","BK4588","IE00B3QW5Z07.USD","BCDF","IE00BN0W2V16.EUR","NDAQ","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","LU0314104364.USD","LU2210150020.SGD","CRVS","IE00BQXX3F31.USD","SG9999014005.SGD","BK4139","SG9999014039.USD","BK4112","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":8,"totalSize":268,"code":"91000000","status":"200"}]}}